← Volver a los artículos

health

Health & Medicine

The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.

HIGH confianza neutral tono

Cobertura (2633 artículos)

Página 1 de 110 Siguiente →
Contáctanos FAQ